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OBJECTIVE — Diabetic patients have a high prevalence of coronary artery disease (CAD),
but timely diagnosis of CAD remains challenging. We assessed the ability of coronary computed
tomography angiography (CCTA) to detect CAD in diabetic patients and to predict subsequent
cardiac events.
RESEARCH DESIGN AND METHODS — We analyzed 140 diabetic patients without
known CAD undergoing CCTA; 1,782 patients without diabetes were used as a control group.
Besides calcium scoring and the degree of the most severe stenosis, the atherosclerotic burden
score counting the number of segments having either a nonstenotic plaque or a stenosis was
recorded. The primary end point was a composite of hard cardiac events deﬁned as all-cause
death, nonfatal myocardial infarction, or unstable angina requiring hospitalization.
RESULTS — During a mean follow-up of 33 months, there were seven events in the diabetic
group and 24 events in the control group. The best predictor in diabetic patients was the
atherosclerotic burden score: the annual event rate ranged from 0.5% for patients with 5
lesions to 9.6% for patients with 9 lesions, resulting in a hazard ratio (HR) of 1.3 (95% CI
1.1–1.7) for each additional lesion (P  0.005). For comparison, in nondiabetic patients the
annual event rate ranged from 0.3 to 2.2%, respectively, resulting in an HR of 1.2 (95% CI
1.1–1.3, P  0.001). The atherosclerotic burden score improved the prognostic value of con-
ventional risk factors signiﬁcantly (P  0.001).
CONCLUSIONS — In diabetic patients without known CAD, CCTA can identify a patient
group at particularly high risk for subsequent hard cardiac events.
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D
iabetes is associated with a mark-
edly increased risk for coronary ar-
tery disease (CAD), and CAD is the
most common cause of death in diabetic
adults (1). Although primary prevention
measures for CAD are recommended for
all diabetic patients (2), additional thera-
pies are indicated where known CAD is
present, e.g., institution of -blocker
therapy, and goals for secondary preven-
tion are more stringent, including an LDL
cholesterol target 70 mg/dl (3). For an
optimized prevention regimen, early de-
tection of CAD is therefore of signiﬁcant
importance in diabetic patients. Unfortu-
nately, the sensitivity of clinical risk as-
sessment is limited, mainly because
typical symptoms of ischemia are often
absent, and cardiac stress imaging tests
also have a limited negative predictive
value in these patients (4). By virtue of its
ability to detect both coronary stenoses
and calciﬁed and noncalciﬁed plaques,
coronary computed tomography angiog-
raphy(CCTA)maybeareasonableoption
to close this diagnostic gap.
During the last few years, CCTA has
emergedasawidelyusedimagingmodal-
ity for detection or exclusion of obstruc-
tive CAD, replacing invasive coronary
angiography in certain conditions (5). In
addition, several studies demonstrated
the usefulness of CCTA as a prognostic
tool for prediction of subsequent cardiac
events (6–8).
For diabetic patients undergoing
CCTA, an increased prevalence of ob-
structiveandnonobstructiveCADwasre-
cently demonstrated (9,10), but up to
now, no data are available relating to how
this observation inﬂuences further clini-
cal outcome. Therefore, the aim of this
study was twofold: to assess the preva-
lence of CAD by CCTA in diabetic pa-
tients without known CAD and to
investigate the predictive value of CCTA
on incident cardiac events.
RESEARCH DESIGN AND
METHODS— The study population
consisted of all consecutive patients un-
dergoing CCTA in our institution be-
tween 1 December 2003 and 29 February
2008, for evaluation of suspected CAD.
Exclusion criteria were 1) typical angina
pectoris,2)ahistoryofmyocardialinfarc-
tion including electrocardiographic signs
of a silent myocardial infarction, 3) a his-
tory of coronary revascularization, either
bypercutaneouscoronaryinterventionor
bypass or otherwise known CAD, 4) ab-
sence of stable sinus rhythm during the
investigation, and 5) a life-threatening
conditions. Patients were subdivided ac-
cording to the presence of diabetes, de-
ﬁned as current treatment with insulin or
oral hypoglycemic medication or dietetic
control of blood glucose levels in patients
having elevated fasting blood glucose lev-
els or an abnormal glucose tolerance test
based on the World Health Organization
criteria (11).
Written informed consent was ob-
tained from all patients before examina-
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performedbeforeexamination,andinfor-
mation about age, patients’ height and
weight, history of cardiac disease, and
presentcomplaintswascollected.Thefol-
lowingcardiacriskfactorswererecorded:
1) presence and degree of hypertension,
2) diabetes (see deﬁnition above), 3)
smoking (deﬁned as current smoker or
previoussmokerwithinthelastyear),and
4) a positive family history (deﬁned as the
presence of CAD in ﬁrst-degree relatives
aged 55 years for male or 65 years for
female). From these data, the Framing-
ham risk score with the established cate-
gorical model using LDL cholesterol
according to Wilson et al. (12) was calcu-
lated. The study design was approved by
the local ethics committee.
Image acquisition and analysis
The detailed multislice computed tomog-
raphy scan protocol is described else-
where (13). Images for calcium scoring
were acquired by a non–contrast-
enhanced sequential scan and analyzed
with a commercially available software
package (Siemens CalciumScore; Sie-
mens, Erlangen, Germany). For CCTA, a
bolus-timing test scan using 10–20 ml of
contrast material (iomeprol, Imeron 350,
iodine content 350 mg/ml; Bracco Altana
Pharma, Konstanz, Germany) followed
by a 50-ml saline chaser was used. After
administration of 80–140 ml of contrast
material individually adjusted to the se-
lectedtablefeedandscanrangeatarateof
4–6 ml/s followed by a 50-ml saline
chaser, the CCTA images were acquired.
Dose reduction strategies such like elec-
trocardiographicgatedtubecurrentmod-
ulationorreducedtubevoltagewereused
whenever feasible.
For image analysis, the coronary ar-
tery tree was segmented according to the
modiﬁed American Heart Association
classiﬁcation (14). Each segment with a
diameter 1.5 mm was evaluated by two
experienced readers (one radiologist and
one cardiologist). Any disagreement was
settledbyconsensus.Thedegreeofsteno-
sis was rated visually using four groups:
no relevant stenosis (25%), mild steno-
sis (25–49%), moderate stenosis (50–
74%), and severe stenosis (75%). If a
moderate or severe stenosis could not be
excludedbecauseofartifacts,thesegment
wasclassiﬁedashavingamoderatesteno-
sis.Inaddition,foreachsegmentthepres-
ence of calcium and the presence of
noncalciﬁed and mixed plaques were as-
sessed. Noncalciﬁed plaques were de-
ﬁned as any discernible structure in the
coronary artery wall with a computed to-
mographic density less than the contrast-
enhanced coronary lumen but greater
than the surrounding connective tissue.
Plaques meeting these criteria, but addi-
tionally showing calciﬁcation, were clas-
siﬁed as mixed plaques. All patients with
nonobstructive and obstructive CAD
were advised to work vigorously to lower
theircardiovascularriskproﬁleanduseof
aspirin and statins was recommended, if
feasible. In addition, all patients with ob-
structive CAD were advised to undergo
invasive angiography. From the primary
analysis the following CCTA parameters
were calculated:
Coronary obstruction score. The most
severe stenosis of any segment 1.5 mm
in diameter categorized as follows: score
0: all evaluable coronary segments
25%;score1:atleastoneevaluablecor-
onary segment with mild stenosis (25–
49%); score 2: at least one evaluable
coronary segment with moderate stenosis
(50–74%);andscore3:atleastoneevalu-
able coronary segment with severe steno-
sis (75%).
Atherosclerotic burden score. The
number of segments with any stenosis
25% or any nonobstructive calciﬁed,
mixed or noncalciﬁed plaques, irrespec-
tive of the degree of stenosis.
Follow-up
Follow-up information was gathered by
clinical visits, telephone contact, or ques-
tionnaire sent by mail. We veriﬁed all re-
ported events by hospital records or
contact with the attending physician.
The primary end point of interest was
a composite of hard cardiac events de-
ﬁned as all-cause death, nonfatal myocar-
dial infarction, or unstable angina
requiring hospitalization. The deﬁnition
of nonfatal myocardial infarction was
based on the criteria of typical acute chest
pain and persistent ST-segment elevation
or positive cardiac enzymes. Unstable an-
ginapectoriswasdeﬁnedaccordingtothe
guidelinesoftheEuropeanSocietyofCar-
diology (15) as typical acute chest pain
with negative cardiac enzymes, if CAD
could not be excluded as the cause of
symptoms.
Statistical analysis
Categorical variables are expressed as fre-
quenciesandpercentagesandcontinuous
variables are expressed as means  SD;
comparisons were done by a Fisher exact
test or Student t test. Event-free survival
was analyzed using the Cox proportional
hazards model. To avoid overﬁtting of
multivariable analysis, only parameters
showing a signiﬁcant correlation in uni-
variate analysis were included into the
model. To improve normal distribution,
calcium scoring was included as its loga-
rithm. Statistical signiﬁcance was ac-
cepted for bilateral P  0.05. The
statisticalpackageRversion2.6.1(16)in-
cludingthepackageDesign(17)wasused
for statistical analysis.
RESULTS
Study population and clinical
characteristics
Atotalof2,021patientsmettheinclusion
criteria. Of these, 1,922 patients could be
contactedforfollow-up,resultinginafol-
low-up rate of 95.1%. Overall, there were
140patientswithdiabetes.In46patients,
blood glucose levels were controlled by
diet, 73 patients took oral antidiabetic
medication, and 21 patients were using
insulin. The control group comprised the
1,782 patients without known diabetes.
The mean duration of follow up was
35.215.4monthsinthediabeticgroup
and 32.8  15.1 months in the control
group.
Diabetic patients were signiﬁcantly
older and more often overweight, and
thereweremorepatientswithhypertension
and hypercholesterolemia among diabetic
patients compared with nondiabetic pa-
tients,resultinginasigniﬁcantlyhigherFra-
mingham risk score. Patients’ sex and the
prevalence of atypical chest pain or dys-
pnea did not differ signiﬁcantly between
both groups. Overall the pretest risk was
signiﬁcantly higher in diabetic patients.
For a detailed description of the patient
characteristics, see Table 1.
Results of CCTA
The results of CCTA and calcium scoring
are summarized in Table 2. Of 140 dia-
betic patients, 19 patients (13%) had
completely normal coronary arteries and
in 16 patients (11%) plaques with a lu-
men narrowing 25% were detected.
Plaques with maximum stenosis between
25 and 49% were found in 38 patients
(27%), plaques with maximum stenosis
between 50 and 74% were found in 53
patients (16%), and plaques with maxi-
mum stenosis 75% were found in 14
patients (10%). Compared with nondia-
betic patients, there were signiﬁcantly
more patients with atherosclerotic
changes (86 vs. 73%, P  0.001) and sig-
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CAD (48 vs. 25%, P  0.001).
Indiabeticpatients,therewereonav-
erage5.2segmentsaffectedbyatheroscle-
rotic lesions: 28% with noncalciﬁed
plaques, 20% with mixed plaques, and
52% with calciﬁed plaques. In nondia-
betic patients, on average only 2.9 seg-
ments showed atherosclerotic changes:
31%withnoncalciﬁedplaques,17%with
mixed plaques, and 52% with calciﬁed
plaques. Whereas the total number of le-
sions was signiﬁcantly higher in diabetic
patients (P  0.001), the plaque compo-
sition was similar (P  0.99).
In diabetic patients, the Agatston
score of 61  56 was signiﬁcantly higher
than that in nondiabetic patients (Agat-
ston score of 13  11, P  0.001).
Cardiac events
In the 140 diabetic patients, there were 5
deaths. In addition, 2 patients had unsta-
ble angina requiring hospitalization. Of
the 1,860 patients without diabetes, 16
patients died. Two patients had nonfatal
myocardial infarctions and 6 patients had
unstableanginarequiringhospitalization.
There was a signiﬁcant difference in
the event rate between diabetic and non-
diabetic patients with respect to the pri-
mary end point of all-cause death,
nonfatal myocardial infarction, and un-
stableanginarequiringhospitalization.In
diabetic patients, the annual event rate
was1.8%(95%CI0.8–3.7%),whereasin
nondiabetic patients it was only 0.5%
(0.3–0.8%), resulting in a hazard ratio
(HR) of 3.5 (1.5–8.2, P  0.003).
Predictive value of CCTA in diabetic
patients
The primary end point correlated best
with the atherosclerotic burden score in
CCTA both in diabetic and nondiabetic
patients. In diabetic patients, the annual
event rate ranged from 0.5% (95% CI
0.1–3.8%) in patients with 5 lesions to
9.6% (4.0–23.1%) for patients with 9
lesions, resulting in an HR of 1.3 (1.1–
1.7,P0.005)foreachadditionallesion.
For comparison, in nondiabetic patients
theannualeventrateincreasedfrom0.3%
(0.1–0.6%)forpatientwith5lesionsto
2.2%(0.9–5.4%)forpatientswith9le-
sions. The HR was 1.2 (1.1–1.3, P 
0.001) (Fig. 1).
In multivariable analysis of the total
patient population, the atherosclerotic
burden score was the only signiﬁcant pre-
dictor for hard cardiac event besides pa-
tient’s age (Table 3). Coronary obstruction
score and calcium score were both signiﬁ-
cantintheunivariatemodelbutcouldnot
add prognostic information on top of the
atherosclerotic burden score. The athero-
sclerotic burden score signiﬁcantly im-
proved the predictive value of a model
includingallconventionalriskfactors,in-
creasing the likelihood ratio from 26.2 to
38.1 (P  0.001).
CONCLUSIONS — The principal
ﬁndings of this study are that 1) the prev-
alence of CAD is signiﬁcantly higher in
diabetic patients compared than nondia-
betic patients, 2) this causes a higher rate
of subsequent cardiac events, and 3)
CCTA has a predictive value in addition
to clinical risk predictors both in diabetic
and nondiabetic patients.
In line with previous publications of
Zeina et al. (10) and Iwasaki et al. (9), in
our study population the prevalence of
CAD reached 86% in diabetic patients
and was signiﬁcantly higher than the
prevalence of 73% in nondiabetic pa-
tients. In addition, diabetic patients had a
Table 1—Clinical characteristics and conventional risk scores
No diabetes Diabetes P value
n 1,782 140
Age 59.0  11.0 64.5  8.3 0.001
Male sex 1,215 (68) 92 (65.7) 0.57
BMI 25.5  3.8 28.3  4.3 0.001
Hypertension 1,008 (57) 109 (78) 0.001
Smoking 624 (35) 46 (33) 0.65
Hypercholesterolemia 907 (51) 86 (61) 0.018
Family history 585 (33) 44 (31) 0.78
Atypical chest pain 693 (39) 51 (36) 0.59
Dyspnea 53 (3) 6 (4) 0.44
Framingham risk score 7.6  6.9 15.2  11.2 0.001
Low 622 (37) 7 (5)
Intermediate 911 (54) 83 (63)
High 143 (9) 43 (32)
Data are means  SD or n (%).
Table 2—Computed tomographic parameters
No diabetes Diabetes P value
n 1,782 140
Obstructive CAD 457 (26) 67 (48) 0.001
Most stenotic lesion
Normal 483 (27) 19 (14)
Nonstenotic plaque 298 (17) 16 (11)
25–49% stenosis 544 (31) 38 (27)
50–75% stenosis 381 (21) 53 (38)
75% stenosis 76 (4) 14 (10)
No. lesions per patient 2.9  3.2 5.2  3.7 0.001
Noncalciﬁed 0.9  0.8 1.4  1.4 0.001
Mixed 0.5  1.1 1.0  1.6 0.001
Calciﬁed 1.5  2.2 2.7  2.8 0.001
Vessels affected 0.001
One-vessel disease 213 (12) 24 (17)
Two-vessel disease 140 (7.86) 23 (16)
Three-vessel disease 93 (5) 20 (14)
Calcium (Agatston) score 13  11 61  56 0.001
0 658 (39) 22 (17)
1–100 579 (34) 45 (34)
100–400 270 (16) 31 (23)
400 188 (11) 35 (26)
Data are means  SD or n (%).
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ments. They showed on average 5 dis-
eased segments, whereas nondiabetic
patients had only 3. In both groups about
two-thirdsofalllesionshadcalciﬁcations.
As also described by Zeina et al. (10),
there was no signiﬁcant difference in
plaque composition between the two
groups.
Toourknowledge,nodataexistatthe
moment relating to how these ﬁndings
correlate with prognosis. In our study
population, diabetic patients had a more
than threefold higher incidence of 1.8%
peryearforhardcardiaceventscompared
withnondiabeticpatients,whohadanan-
nual event rate of 0.5%. The parameter
correlating best with these events both in
the overall population and in diabetic pa-
tientsinparticularwastheatherosclerotic
burden score counting the diseased coro-
nary segments. This good correlation,
paired with the fact that the atheroscle-
rotic burden score remains the only sig-
niﬁcant predictor in a multivariable
analysis, suggests that by directly visual-
izing the atherosclerotic burden, CCTA
might be able to identify exactly those di-
abetic patients who are at high risk for
having cardiac events.
The high prevalence of atheroscle-
roticlesionscombinedwiththegoodpre-
dictivevalueoftheatheroscleroticburden
score makes CCTA particularly useful in
diabetic patients. CCTA can detect ath-
erosclerotic changes early, well before
coronaryobstructionandischemiaoccur;
it can also detect both calciﬁed and non-
calciﬁed plaques and can distinguish be-
tween obstructive and nonobstructive
plaques. This features allow a very com-
prehensive assessment of diabetic pa-
Figure 1—Survival free of hard cardiac events in correlation with the atherosclerosis burden
score,countingthenumberoflesionshavingeithernonstenoticplaquesorstenoses(irrespectiveof
degree), in patients both with and without diabetes. The numbers of patients at risk refer to the
three groups analyzed (top 5, middle 5–9, and bottom 9 diseased segments).
Table 3—Multivariable analysis for prediction of hard cardiac events in all patients
No cardiac
events
Cardiac
events
Univariate model Multivariate model
HR (95% CI) P value HR (95% CI) P value
Diabetes 133 (7) 7 (26) 3.5 (1.5–8.2) 0.001
Hypertension 1,097 (58) 21 (68) 1.5 (0.7–3.2) 0.3
Hypercholesterolemia 973 (51) 20 (65) 1.6 (0.8–3.3) 0.21
Smoking 661 (35) 10 (32) 0.9 (0.4–1.8) 0.68
Family history 622 (33) 7 (23) 0.6 (0.2–1.3) 0.2
Age 58.5  10.9 66.2  8.4 1.1 (1–1.1) 0.001 1.05 (1.02–1.09) 0.006
Male sex 1,284 (68) 24 (77) 1.5 (0.7–3.6) 0.32
Atypical chest pain 736 (39) 9 (29) 0.7 (0.3–1.5) 0.34
Dyspnea 57 (3) 2 (6) 1.9 (0.5–8) 0.38
Atherosclerotic burden score 3.0  3.2 6.6  4.3 1.3 (1.2–1.4) 0.001 1.2 (1.1–1.3) 0.001
Coronary obstruction score 0.9  0.9 1.7  0.9 2.5 (1.7–3.8) 0.001
Calcium score 1.1  1.0 2.2  2.1 2.5 (1.6–3.8) 0.001
Data are means  SD or n (%) unless otherwise indicated. The HR for the calcium score is calculated for a 10-fold increase.
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quitegoodprognosisofan0.5%annual
event rate and could continue to receive
conventional medical therapy and pa-
tients with more extended disease could
beneﬁt from a vigorous treatment of both
diabetes and CAD. In particular, in pa-
tients with very extended CAD (9 coro-
nary segments affected) having a risk of
nearly 10% per year for having a severe
cardiac event, the effort and risks of a in-
tensive blood glucose control combined
with a secondary prevention regimen for
CAD might be justiﬁed even in the ab-
sence of cardiac symptoms. In addition,
obstructive CAD can be detected or ruled
out with high accuracy (5), circumvent-
ing both the limitations of myocardial
stress imaging and the risks of invasive
angiography but providing valuable in-
formation for the selection of patients
who could beneﬁt from timely coronary
revascularization.
Whether an approach such as this is
actually better than the current concepts
and whether CCTA can replace myocar-
dial perfusion imaging as a gatekeeper for
revascularization still need to be assessed
in larger studies, but this study clearly
demonstratesthatCCTAhasthepotential
to identify patients with a particularly
high risk for hard cardiac events in a
group of diabetic patients without known
coronary artery disease.
This study has some limitations. It is
anobservationalstudy,andtheresultof
the investigation guided further treat-
ment, both interventional and medical.
Because most of the patients were re-
ferred from outside cardiologists in
private practice, valid information re-
garding diabetic control or changes of
medication after the investigation is not
available. In addition, the number of di-
abetic patients is small in this unre-
stricted patient population.
In summary, diabetic patients with-
out known CAD undergoing CCTA have
an increased prevalence of both coronary
plaques and obstructive CAD compared
withnondiabeticpatients.Thisresultisin
keeping with an increased risk for hard
cardiac events.
A CCTA atherosclerotic burden
score based on the number of diseased
coronary segments (irrespective of the
degree of stenosis) correlates best with
events during follow-up and can signif-
icantly improve the risk stratiﬁcation
overandabovethatofconventionalrisk
factor assessment. This procedure al-
lows the identiﬁcation of a patient
group of particular high risk for inci-
dent cardiac events.
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